Lawrence represents medical device, pharmaceutical, and biotechnology companies and investors in their corporate transactions, private, venture capital and public securities financings, mergers and acquisitions, licensing, strategic alliances, and technology transfers.
He also has substantial experience in the licensing of new technologies from universities and research institutions. His clients range from early-stage startups to public companies with global operations.
